CN102228476B - Medicament for treating beriberi and technological process thereof - Google Patents
Medicament for treating beriberi and technological process thereof Download PDFInfo
- Publication number
- CN102228476B CN102228476B CN201110162170A CN201110162170A CN102228476B CN 102228476 B CN102228476 B CN 102228476B CN 201110162170 A CN201110162170 A CN 201110162170A CN 201110162170 A CN201110162170 A CN 201110162170A CN 102228476 B CN102228476 B CN 102228476B
- Authority
- CN
- China
- Prior art keywords
- powder
- shell powder
- treatment
- shell
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicines, and in particular relates to a medicament for treating beriberi and a technological process thereof. The medicament for treating the beriberi comprises the following crude materials in portion by weight: 20-50 portions of while borax, 2-8 portions of meretrix shell powder and 3-9 portions of blood clam shell powder. The technological process comprises the following steps of: 1) soaking all kinds of powder in proportion into water, extracting depositions after depositing, and drying in the sun; and 2) smashing and sieving the powder obtained in the step 1), selecting 60-300 meshes of powder, sealing and packaging. In the invention, the technology is simple; the white borax is used as a main crude material and is added with various kinds of natural powder without addition of industrial chemicals, so that the medicament is pollution-free; moreover, the medicament can be used for effectively relieving pains of patients and has the advantages that both prevention effect and cure effect are achieved, foot diseases are alleviated and cured, and a cure course is short.
Description
Technical field
The invention belongs to the field of Chinese medicines, be specifically related to beriberic medicine of a kind of treatment and process thereof.
Background technology
Vitamin B1 deficiency is that a kind of common skin is sick, and according to relevant reports of newspaper, world resident foot bottom PMR is quite high; Account for total population more than 30%; In China the vitamin B1 deficiency patient more than 300,000,000 is just arranged approximately, it is normal and physically and mentally healthy that the erosion of foot bottom eczema has a strong impact on human life, therefore; People still have urgent demand to the beriberic medicine of the treatment that better curative effect is arranged.At present on the market beriberi paste, beriberi liquor kind is a lot, and what have also possibly produce side effect hypersensitive, and what have has a certain effect, but relapse rate is high.
Summary of the invention
The present invention provides beriberic medicine of a kind of treatment and process thereof, and this medicine effectively reduction of patient is painful, has the control dual-purpose, cures fast characteristics.
The beriberic medicine of described a kind of treatment is characterized in that comprising the raw material of following weight portion:
White Borax 20-50 literary composition Concha Meretricis Seu Cyclinae powder 2-8 Tegillarca granosa Linnaeus shell powder 3-9.
The beriberic medicine of described a kind of treatment is characterized in that the weight proportion of each raw material is:
White Borax 30-46 literary composition Concha Meretricis Seu Cyclinae powder 3-7 Tegillarca granosa Linnaeus shell powder 4-8.
The beriberic medicine of described a kind of treatment is characterized in that the weight proportion of each raw material is:
White Borax 35-43 literary composition Concha Meretricis Seu Cyclinae powder 4-6 Tegillarca granosa Linnaeus shell powder 5-7.
The beriberic medicine of described a kind of treatment is characterized in that the weight proportion of each raw material is:
White Borax 40 civilian Concha Meretricis Seu Cyclinae powder 5 Tegillarca granosa Linnaeus shell powder 6.
The beriberic medicine of described a kind of treatment is characterized in that also comprising the raw material of following weight portion:
Shell powder 3-9 dragonfly shell powder 1-7.
The beriberic medicine of described a kind of treatment is characterized in that also comprising the raw material of following weight portion:
Shell powder 6 dragonfly shell powder 4.
The beriberic medicine of described a kind of treatment is characterized in that also comprising the raw material of following weight portion:
Alum powder 2-8 Pulvis Talci 1-7.
The beriberic medicine of described a kind of treatment is characterized in that also comprising the raw material of following weight portion:
Alum powder 5 Pulvis Talci 4.
The beriberic medicine of described a kind of treatment is characterized in that the weight proportion of each raw material is:
White Borax 40 civilian Concha Meretricis Seu Cyclinae powder 5 Tegillarca granosa Linnaeus shell powder 6 shell powders 6 dragonfly shell powder 4 alum powders 5 Pulvis Talci 4.
The beriberic medicine of described a kind of treatment is characterized in that adopting following process to make:
1) the various powder with proportional quantity are soaked in water, and post precipitation extracts deposit, dries;
2) with step 1) gained crushing screening, select the powder of 60-300 sieve mesh, sealed package gets final product.
The present invention compared with prior art has the following advantages and good effect:
1, invented technology is simple, utilizes white Borax to be primary raw material, and various natural powders in addition, need not add industrial chemicals, environmentally safe.
2, drug regimen makes each efficacy of drugs produce synergism, thereby can effectively and apace treat the erosion of foot bottom eczema, the wherein white sweet salty cold of Borax performance; Damp eliminating, parasite killing, antipruritic, deodorization, external heat-clearing and toxic substances removing, promoting blood circulation to remove obstruction in the collateral; The detumescence spasmolytic has curative effect preferably to vitamin B1 deficiency; Conch Meretricis seu Cyclinae shell mealiness can be salty-cold, can hard masses softening and resolving, contain the mineral of needed by human such as various vitamin that human body is prone to absorb and calcium, potassium, phosphorus, magnesium, ferrum, and coordinating the actions of various ingredients in a prescription, treatment foot bottom eczema is rotten to the corn; The Tegillarca granosa Linnaeus shell mealiness can be sweet flat, blood circulation promoting and blood stasis dispelling, and it is puckery to control the blood stasis resistance, walks lamely, and has the superpower benefit of extremely strong control and relaxes more the effect of treatment with foot trouble.
3, also added shell powder, the combination of dragonfly shell powder, the shell powder nature and flavor are salty-cold, eliminating dampness and dredging channels, heat clearing and damp drying, killing parasites for relieving itching; Dragonfly shell powder property of medicine salty in the mouth is cool, subduing swelling and detoxicating.
4, reusing white Borax damp eliminating parasite killing is monarch drug; Shell powder, eliminating dampness and dredging channels, dragonfly shell mealiness salty in the mouth is cool; Subduing swelling and detoxicating is a ministerial drug; Assistant is replenished needed by human body such as various vitamin that human body is prone to absorb and calcium, potassium, phosphorus, magnesium, ferrum with meretrix meretrix powder mineral mixes all medicines for making, and reaches the good effects of damp eliminating, treatment.
5, the present invention has also added alum powder, Pulvis Talci on the basis of said medicine, and the acid of alum powder nature and flavor is cold, detoxifcation parasite killing, removing dampness to relieve itching; The effect of eliminating dampness and dredging channels, Pulvis Talci is sweet in flavor and cold in property, clearing away heat and removing summer-heat, skin ulcer is held back in damp eliminating; Make effect of the present invention stronger, it is faster to take effect, and treats beriberic curative effect the best.
The specific embodiment
Below through test the present invention is described further, set forth the beneficial effect of medicine according to the invention, these tests are for placing medicine of the present invention shoe pad internal therapy patient's clinical observation on the therapeutic effect test.
[Test Example 1]
Drug therapy damp eliminating of the present invention, parasite killing, antipruritic, deodorant clinical observation.
Adopt prescription as follows: white Borax 20-50 g literary composition Concha Meretricis Seu Cyclinae powder 2-8 g Tegillarca granosa Linnaeus shell powder 3-9 g.
1, physical data
Accept the patient for medical treatment: 154 examples, male 104 people, women 45 people, 18-62 years old ages.Clinical manifestation is for wet, and is smelly, malaise symptoms such as itch.The course of disease 1-6 years.
2, Therapeutic Method
Use shoe pad every day, next day transposing is once two, two weeks of logotype.
3, curative effect method evaluation criteria
Cure: foot is wet, foot odor, and malaise symptoms complete obiterations such as foot pruritus do not have recurrence in 1 year.
Produce effects: in pad back half an hour to seven day, foot is wet, foot odor, and malaise symptoms complete obiterations such as foot pruritus have recurrence to continue to use this medicine in half a year.
Effectively: foot is wet, and foot odor, foot pruritus are clearly better or alleviate, and needs often to use this medicine.
Invalid: foot is wet, foot odor, and malaise symptoms such as foot pruritus do not have obvious improvement, use the other drug treatment instead.
Therapeutic outcome is seen table 1:
The observation of curative effect of table 1 after treatment
Annotate: treatment time is in March, 2001, follows up a case by regular visits to final time and be 20 Mays in year one by one
To sum up, in 14 days treatment, treat 154 people with shoe pad, the result cures 74 people, produce effects 51 people, effective 19 people, invalid 10 people.Cure 48.1%, produce effects 33.1%, effective 12.3%, total effective rate 93.5%.
[Test Example 2]
Drug therapy damp eliminating of the present invention, parasite killing, antipruritic, deodorant clinical observation.
Adopt prescription as follows: white Borax 20-50 g literary composition Concha Meretricis Seu Cyclinae powder 2-8 g Tegillarca granosa Linnaeus shell powder 3-9 g shell powder 3-9 g dragonfly shell powder 1-7g alum powder 2-8g Pulvis Talci 1-7g.
1, physical data
Accept the patient for medical treatment: 97 examples, male 52 people, women 45 people, 18-62 years old ages.Clinical manifestation is for wet, and is smelly, malaise symptoms such as itch.The course of disease 1-6 years.
2, Therapeutic Method
Use shoe pad every day, next day transposing is once two, two weeks of logotype.
3, curative effect method evaluation criteria
Cure: foot is wet, foot odor, and malaise symptoms complete obiterations such as foot pruritus do not have recurrence in 1 year.
Produce effects: in pad back half an hour to seven day, foot is wet, foot odor, and malaise symptoms complete obiterations such as foot pruritus have recurrence to continue to use this medicine in half a year.
Effectively: foot is wet, and foot odor, foot pruritus are clearly better or alleviate, and needs often to use this medicine.
Invalid: foot is wet, foot odor, and malaise symptoms such as foot pruritus do not have obvious improvement, use the other drug treatment instead.
Therapeutic outcome is seen table 2:
The observation of curative effect of table 2 after treatment
Annotate: treatment time is in March, 2006, follows up a case by regular visits to final time and be 20 Mays in year one by one
To sum up, in 14 days treatment, treat 97 people with shoe pad, the result cures 51 people, produce effects 33 people, effective 10 people, invalid 3 people.Cure 52.6%, produce effects 34.0%, effective 10.3%, total effective rate 96.9%.
[Test Example 3]
Drug therapy damp eliminating of the present invention, parasite killing, antipruritic, deodorant clinical observation.
Adopt prescription as follows: white Borax 40 g literary composition Concha Meretricis Seu Cyclinae powder 5 g Tegillarca granosa Linnaeus shell powder 6 g shell powder 6g dragonfly shell powder 4g alum powder 5g Pulvis Talci 4g.
1, physical data
Accept the patient for medical treatment: 90 examples, male 44 people, women 46 people, 18-62 years old ages.Clinical manifestation is for wet, and is smelly, malaise symptoms such as itch.The course of disease 1-6 years.
2, Therapeutic Method
Use shoe pad every day, next day transposing is once two, one week of logotype.
3, curative effect method evaluation criteria
Cure: foot is wet, foot odor, and malaise symptoms complete obiterations such as foot pruritus do not have recurrence in 1 year.
Produce effects: in pad back half an hour to seven day, foot is wet, foot odor, and malaise symptoms complete obiterations such as foot pruritus have recurrence to continue to use this medicine in half a year.
Effectively: foot is wet, and foot odor, foot pruritus are clearly better or alleviate, and needs often to use this medicine.
Invalid: foot is wet, foot odor, and malaise symptoms such as foot pruritus do not have obvious improvement, use the other drug treatment instead.
Therapeutic outcome is seen table 3:
The observation of curative effect of table 3 after treatment
Annotate: treatment time is in March, 2009, follows up a case by regular visits to final time and be 20 Mays in year one by one
To sum up, in 7 days treatment, treat 90 people with shoe pad, the result cures 60 people, produce effects 13 people, effective 5 people, invalid 2 people.Cure 66.7%, produce effects 14.4%, effective 5.6%, total effective rate 97.8%.
[Test Example 4]
Drug therapy of the present invention is invigorated blood circulation, the clinical observation of collateral dredging, detumescence, spasmolytic.
Adopt prescription as follows: white Borax 35-43 literary composition Concha Meretricis Seu Cyclinae powder 4-6 Tegillarca granosa Linnaeus shell powder 5-7 shell powder 3-9g dragonfly shell powder 1-7g alum powder 2-8g Pulvis Talci 1-7g.
1, physical data
Accept patient's 95 examples for medical treatment, blood stasis 57 people wherein, male 45 people, women 12 people.Cramp patient 35 people, male 18 people, women 17 people, 21-63 years old ages.Clinical manifestation is malaise symptoms such as legs and feet edema, numbness, ache, cramp.The course of disease 1-10 years.
2, treat the method for controlling
Use this shoe pad, next day transposing a pair of connects and filled up for two week or three weeks.
3, curative effect method evaluation criteria
Produce effects: spasmolytic detumescence in the twenty four hours of pad back, collateral dredging is invigorated blood circulation.All malaise symptoms complete obiterations in the twenty four hours are observed and were not had recurrence in three months.
Effectively: make moderate progress with malaise symptoms in the back 12 hours, malaise symptoms complete obiteration in three days, the recurrence interval phase prolongs, and needs often subsequent use.
Invalid: all malaise symptoms do not have obvious improvement, do not reach effective standard person.
Treatment is controlled the result and is seen table 4:
The observation of curative effect of table 4 after treatment
In 7 days treatment, treat 95 examples with first Golconda shoe pad, produce effects 59 people as a result, effective 33 people, invalid 3 people.Produce effects 62.1%, effective 33.7%, total effective rate 97.9%.
[Test Example 5]
The present invention is used for eczema, erosion, blood stasis, hinder puckery, the clinical observation of limping.
Adopt prescription as follows: white Borax 30-46 literary composition Concha Meretricis Seu Cyclinae powder 3-7 Tegillarca granosa Linnaeus shell powder 4-8 shell powder 3-9g dragonfly shell powder 1-7g alum powder 2-8g Pulvis Talci 1-7g.
1, physical data
Accept patient's 48 examples for medical treatment, rotten to the corn 36 examples of eczema wherein, 12 examples of walking lamely, male 38 people, women 10 people, 7-50 years old ages.Clinical manifestation is puckery for the resistance of walking lamely, and blood stasis is rotten to the corn, malaise symptoms such as eczema.The course of disease 1-10 years.
2, Therapeutic Method
Use this shoe pad every day, next day transposing a pair of connects and filled up one month or two months.
3, curative effect method evaluation criteria
Produce effects: use in the shoe pad one to three day, eczema, erosion, blood stasis hinder puckeryly, and the grade of walking lamely does not make the symptom complete obiteration.Recur again in half a year and continue to use this medicine.
Effectively: eczema, erosion, blood stasis hinders puckeryly, and walking lamely is clearly better or obviously alleviates needs often to use this medicine.
Invalid: eczema, erosion, blood stasis hinders puckeryly, and malaise symptoms such as limping do not have obvious improvement, use the other drug treatment instead.
Efficacy result is seen table 5:
The observation of curative effect of table 5 after treatment
In 2 days treatment, treat 48 people with first Golconda shoe pad, produce effects 35 people as a result, effective 10 people, invalid 3 people.Produce effects 72.9%, effective 20.8%, total effective rate 93.7%.
Pharmaceutical formulation of the present invention adopts the multiple natural powder of folk tradition formulated for applying for everybody through the research repeatedly more than 8 years, is applied to foot bottom eczema, erosion, blood stasis, puckery, the limping of resistance.Like above-mentioned experimental example, through more than 500 patients' clinical verification, the present invention have the superpower benefit of extremely strong control suffer from, foot relax more, the advantage of the strange speed of the magical effect, be that human health prevents the satisfied special shoe pad of subsequent use effect.
Medicine of the present invention can be processed conventional exterior-applied prescription, also can be applied to powder for dipping feet sandbag, glove; Waist support, medicated cushion, medicine is with clothing etc.; But these can not be used to limit protection of the present invention, should be pointed out that the scheme of all application the present invention designs all should belong to protection scope of the present invention.
The points for attention that the present invention uses:
1, high heating, thermoesthesia obstacle person forbidding.
2, acute soft tissue injury is asked after 24 hours and is used.
3, in patient's body cardiac pacemaker is housed and forbidding, allergies person is arranged, please under physician guidance, use.
4, rubescent like the part appearance, the scorching hot normal phenomenon that belongs to, product takes off back phenomenon Lock-out.
5, taboo is taken care to contact eyes, can not enter the mouth, and the anemia of pregnant woman should not use.
6, forbid to immerse bubbly water, with the abluent washing, available clear water is not cleaned gently, puts under the sunlight to dry, and most convenient is effective.
Claims (6)
1. treat beriberic medicine for one kind, it is characterized in that processing by the raw material of following weight portion:
White Borax 20-50 literary composition Concha Meretricis Seu Cyclinae powder 2-8 Tegillarca granosa Linnaeus shell powder 3-9, and adopt following process to make:
1) the various powder with proportional quantity are soaked in water, and post precipitation extracts deposit, dries;
2) with step 1) gained crushing screening, select the powder of 60-300 sieve mesh, sealed package gets final product.
2. the beriberic medicine of a kind of treatment as claimed in claim 1 is characterized in that the weight proportion of each raw material is:
White Borax 30-46 literary composition Concha Meretricis Seu Cyclinae powder 3-7 Tegillarca granosa Linnaeus shell powder 4-8.
3. the beriberic medicine of a kind of treatment as claimed in claim 1 is characterized in that the weight proportion of each raw material is:
White Borax 35-43 literary composition Concha Meretricis Seu Cyclinae powder 4-6 Tegillarca granosa Linnaeus shell powder 5-7.
4. the beriberic medicine of a kind of treatment as claimed in claim 1 is characterized in that the weight proportion of each raw material is:
White Borax 40 civilian Concha Meretricis Seu Cyclinae powder 5 Tegillarca granosa Linnaeus shell powder 6.
5. treat beriberic medicine for one kind, it is characterized in that processing by the raw material of following weight portion:
White Borax 20-50 literary composition Concha Meretricis Seu Cyclinae powder 2-8 Tegillarca granosa Linnaeus shell powder 3-9 shell powder 3-9 dragonfly shell powder 1-7 alum powder 2-8 Pulvis Talci 1-7, and adopt following process to make:
1) the various powder with proportional quantity are soaked in water, and post precipitation extracts deposit, dries;
2) with step 1) gained crushing screening, select the powder of 60-300 sieve mesh, sealed package gets final product.
6. the beriberic medicine of a kind of treatment as claimed in claim 5 is characterized in that the weight proportion of each raw material is:
White Borax 40 civilian Concha Meretricis Seu Cyclinae powder 5 Tegillarca granosa Linnaeus shell powder 6 shell powders 6 dragonfly shell powder 4 alum powders 5 Pulvis Talci 4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110162170A CN102228476B (en) | 2011-06-16 | 2011-06-16 | Medicament for treating beriberi and technological process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110162170A CN102228476B (en) | 2011-06-16 | 2011-06-16 | Medicament for treating beriberi and technological process thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102228476A CN102228476A (en) | 2011-11-02 |
| CN102228476B true CN102228476B (en) | 2012-09-19 |
Family
ID=44841108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110162170A Active CN102228476B (en) | 2011-06-16 | 2011-06-16 | Medicament for treating beriberi and technological process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102228476B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102861253A (en) * | 2012-08-30 | 2013-01-09 | 赵银金 | Foot immersing medicament for treating dermatophytosis |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1212162A (en) * | 1998-10-23 | 1999-03-31 | 张承凯 | High efficiency ointment for curing beri-beri (tinea pedis) |
| CN1258509A (en) * | 1998-12-31 | 2000-07-05 | 刘科林 | Beri-beri medicine powder |
| CN1679723A (en) * | 2005-01-29 | 2005-10-12 | 白景山 | Beriberi paste |
| CN1720972A (en) * | 2005-06-29 | 2006-01-18 | 凌沛学 | Chinese medicine for treating dermatomycosis and its preparing process |
| CN101112454A (en) * | 2007-07-27 | 2008-01-30 | 李宝笃 | Spraying agent for treating beriberi and method for preparing the same |
| CN101856376A (en) * | 2009-04-11 | 2010-10-13 | 张毅 | Chinese medicament for treating dermatophytosis |
-
2011
- 2011-06-16 CN CN201110162170A patent/CN102228476B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1212162A (en) * | 1998-10-23 | 1999-03-31 | 张承凯 | High efficiency ointment for curing beri-beri (tinea pedis) |
| CN1258509A (en) * | 1998-12-31 | 2000-07-05 | 刘科林 | Beri-beri medicine powder |
| CN1679723A (en) * | 2005-01-29 | 2005-10-12 | 白景山 | Beriberi paste |
| CN1720972A (en) * | 2005-06-29 | 2006-01-18 | 凌沛学 | Chinese medicine for treating dermatomycosis and its preparing process |
| CN101112454A (en) * | 2007-07-27 | 2008-01-30 | 李宝笃 | Spraying agent for treating beriberi and method for preparing the same |
| CN101856376A (en) * | 2009-04-11 | 2010-10-13 | 张毅 | Chinese medicament for treating dermatophytosis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102228476A (en) | 2011-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101785837B (en) | Traditional Chinese medicine lotion for tinea manus and pedis treatment | |
| CN101352505B (en) | Bone fracture setting medicine powder for treating traumatic injury | |
| CN102091205A (en) | Liniment containing fortune's drynaria rhizome, safflower and frankincense and preparation method thereof | |
| CN103191257A (en) | Bone healing tincture | |
| CN101773577B (en) | Kanto tea bath package for curing rheumatism, arthritis and senile degenerative joint diseases | |
| CN101361876B (en) | Wound-healing tissue-promoting powder and preparation method thereof | |
| CN100356964C (en) | Tendon-relaxing pain-relieving Chinese herbal powder | |
| CN102008610A (en) | Traditional Chinese medicine composition for curing hyperosteogeny | |
| CN104116763A (en) | Taxus chinensis itching eliminating and relieving product and preparation method thereof | |
| CN107137471A (en) | A kind of Traditional Chinese medicine used as analgesic composition and its preparation method and application | |
| CN102228476B (en) | Medicament for treating beriberi and technological process thereof | |
| CN104116865B (en) | Stopping muscles and bones pain dissipates | |
| CN101085283B (en) | Vein relaxing externally used lotion for dermatosis | |
| CN102872248B (en) | Traditional Chinese medicine for treating beriberi and tinea manus and pedis | |
| CN107802814A (en) | Chinese medicine composition and its manufactured plaster and preparation method | |
| CN103239660A (en) | Medicine for treating beriberi | |
| CN102370834A (en) | Bone-knitting powder | |
| CN101926977A (en) | Medicament for expelling wind, removing dampness, activating blood and relieving pain | |
| CN101361868B (en) | Traditional Chinese medicine combination for treating rheumatism | |
| CN105078105A (en) | Healthcare traditional Chinese salt pillow | |
| CN105412206A (en) | Traditional Chinese medicine preparation with relaxing tendon and dissipating hard mass effects | |
| CN104740034A (en) | External medicine pad for treating heel bony spur and preparation method of external medicine pad | |
| CN102579581A (en) | Medicine for treating lumbar disc herniation and preparation method thereof | |
| CN109419868A (en) | A kind of externally applied drug for treating soft tissue injury | |
| CN107158126A (en) | A kind of anti-inflammatory analgetic composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |